Robert Michael Dudley

Insider Reports History

Location
Boston, MA
Signature
/s/ Thomas A. Fitzgerald, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Michael Dudley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Transcode Therapeutics, Inc. Chief Executive Officer, Director Common Stock 180K $91.9K $0.51 28 Sep 2023 Direct
Transcode Therapeutics, Inc. Chief Executive Officer, Director Stock Option (right to buy) 735K 19 May 2023 Direct

Insider Reports Filed by Robert Michael Dudley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNAZ Transcode Therapeutics, Inc. 28 Sep 2023 1 $50K 4 Chief Executive Officer, Director 02 Oct 2023, 16:37
RNAZ Transcode Therapeutics, Inc. 20 Jun 2023 2 $48.7K 4 Chief Executive Officer, Director 22 Jun 2023, 18:23
RNAZ Transcode Therapeutics, Inc. 09 Jun 2023 1 $52.4K 4/A Chief Executive Officer, Director 14 Jun 2023, 16:16
RNAZ Transcode Therapeutics, Inc. 19 May 2023 1 $0 4 Chief Executive Officer, Director 19 May 2023, 20:06
RNAZ Transcode Therapeutics, Inc. 12 Dec 2022 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 14 Dec 2022, 19:11
RNAZ Transcode Therapeutics, Inc. 14 Sep 2022 1 $23K 4 Chief Executive Officer, Director, 10%+ Owner 16 Sep 2022, 18:44
RNAZ Transcode Therapeutics, Inc. 27 May 2022 2 $55.4K 4 Chief Executive Officer, Director, 10%+ Owner 01 Jun 2022, 16:01
RNAZ Transcode Therapeutics, Inc. 01 Feb 2022 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 03 Feb 2022, 05:03
RNAZ Transcode Therapeutics, Inc. 08 Jul 2021 0 $0 3 Chief Executive Officer, Director, 10%+ Owner 08 Jul 2021, 21:54